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ScienceDirectAntigen-presenting cells (APCs) capture and present
pathogens to T cells, thus arousing adaptive immune
responses geared at the elimination of these invaders. In APCs,
pathogens acquired from the extracellular space intersect with
MHC class II (MHC-II) molecules in the endolysosomal system,
where processing and loading of antigenic peptides occur. The
resulting complexes can then be directed to the cell surface for
recognition by T cells. To achieve this, the endosomal pathway
of APCs must undergo dramatic rearrangements upon
pathogen encounter. In this review we discuss recent strides in
our understanding of how APCs modulate the organization and
function of their endolysosomes to best suit different stages of
antigen acquisition, processing and presentation cascade.
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Introduction
The endolysosomal system functions as a trading plat-
form through which the cell and its environment
exchange information and goods in order to maintain
homeostasis and communicate impending predicaments.
To enable reception and utilization of a wide variety of
materials and signals, this system comprises many differ-
ent flavors of vesicular membrane carriers, whose inter-
actions with one another determine downstream cellular
outcomes. Following internalization from the extracellu-
lar space, endosomes undergo progressive maturation,
characterized by acidification and sorting of ubiquitinated
cargoes into intraluminal vesicles (ILVs). The resulting
multivesicular bodies (MVBs) can subsequently fuse with
lysosomes to deliver the contents of their ILVs forwww.sciencedirect.com degradation [1], while materials not intended for degra-
dation recycle from the limiting endosomal membrane
back to the cell surface. Cytoplasmic cargoes encapsu-
lated within autophagosomes also feed into this endocytic
tract for access to the proteolytic compartment, thus
allowing cross-talk between intracellular and extracellular
domains [2]. This diverse system of vesicles must work in
concert to fulfill its roles as the cell’s sensory platform and
digestive organelle. To ensure controlled uptake and
progression of cargoes through the system, cells have
evolved strategies to organize and manipulate their endo-
lysosomal repertoire in space and time. In this review, we
discuss the nature of these strategies and their relation-
ship(s) to endocytic function at the host–pathogen
interface.
As the main port of cellular entry, the endocytic pathway
is routinely hijacked by a wide variety of pathogens
during infection [3]. Accordingly, the endolysosomal sys-
tem has adapted to serve as the front line of the immune
response. This is perhaps best exemplified by profes-
sional APCs—immune cells tasked with detection and
presentation of antigens. APCs, including dendritic cells
(DCs), macrophages, B cells and thymic epithelial cells
rely profoundly on the endocytic pathway to fulfill their
physiological function, as it allows them to take up,
process and display antigens in a controlled manner.
Following internalization, pathogenic constituents are
transported to late endosomal compartments, where they
are processed into short peptides and subsequently
loaded onto MHC-II molecules for export to the plasma
membrane. Once peptide-MHC-II complexes (p-MHC-
II) reach the cell surface, they can activate CD4 T cells,
stimulating differentiation into T helper cell subsets
essential for proper activation of cytotoxic T cells and
differentiation of B cells [4]. Consequently, disturbances
in the workings of the endolysosomal system, caused for
instance by pathogens [5], metabolites or drugs, can
directly impair antigen processing and presentation,
resulting in hampered immunity. While we understand,
to some extent, the general mechanisms controlling
endosome behavior and function, our knowledge of endo-
somal perturbations in the context of antigen presentation
is still quite poor. Below we review our current under-
standing of endolysosomal architecture, motility, and
membrane dynamics in APCs, with emphasis on the
imperative changes occurring during maturation of these
cells upon pathogen encounter. We also debate how
deregulation of MHC-II trafficking and autophagy inCurrent Opinion in Immunology 2019, 58:1–8
2 Antigen processingantigen-presenting cells can contribute to the develop-
ment of auto-immunity.
‘Class II’ goes to the MIIC
Following their biosynthesis and association with the
invariant chain chaperone (Ii) in the endoplasmic reticu-
lum (ER), MHC-II dimers traffic via the trans-Golgi
network to the so-called MHC-II compartment (MIIC)
known to host antigen processing and peptide loading
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Schematic overview of MHC-II antigen presentation in APCs before
maturation.
In immature APCs, MHC-II in complex with the invariant chain Ii exits
the biosynthetic tract via the TGN and is targeted to the endosomal
pathway either directly or via the plasma membrane. Once MHC-II/Ii
complex reaches the acidic and proteolytic MHC-II compartment
(MIIC), much of Ii is trimmed away and MHC-II/CLIP awaits antigens.
After sorting into ILVs, MHC-II interacts with HLA-DM for peptide
loading. As APCs sample their environment and collect antigens (Ag)
through various pathways (exogenous: endocytosis, phagocytosis;
endogenous: autophagy), these are routed to the MIIC for processing,
loading, and presentation. This requires retrograde vesicle transport
toward the microtubule minus-end where antigen processing
compartments are retained by ER-associated RNF26. Fusion with
these endolysosomes is then orchestrated by the small GTPases Rab7
and Arl8b in conjunction with their effectors RILP, PLEKHM1 and
HOPS. Additionally, Arl14/Myo1e complex inhibits export of p-MHC-II
complexes to the plasma membrane.
Current Opinion in Immunology 2019, 58:1–8 maturation state, they generally comprise late endosomes
or lysosomes characterized by intraluminal membranes,
acidic pH, and mild proteolytic activity—all attributes
that favor antigen processing and preservation of resulting
epitope integrity [4]. When antigens acquired through
endocytosis, phagocytosis, macropinocytosis (exogenous),
or autophagy (endogenous) enter the endocytic tract, they
are directed to the MIIC for degradation [7,8]. Antigenic
peptides produced during this process can then be
directly loaded onto MHC-II residing in the same com-
partment. To facilitate peptide loading, MHC-II-associ-
ated Ii must undergo proteolysis [9], leaving only the
contiguous internal segment of Ii (CLIP) within the
MHC-II peptide-binding groove [10]. The endosomal
chaperone HLA-DM then mediates removal of CLIP,
creating an opportunity for antigen-derived peptides to
bind [11].
Under steady state conditions, most MHC-II dimers,
along with HLA-DM, are sequestered onto ILVs of the
MIIC [12]. Intraluminal sorting of MHC-II, as well as
vesicle budding and scission, is orchestrated by the
endosomal sorting complexes required for transport
(ESCRT) [13] and likely requires MHC-II ubiquitina-
tion by ligases of the membrane-associated RING-CH
(MARCH) family [14], although the impact of this
modification on antigen presentation remains debated
[15]. Before incorporation into ILVs, ubiquitin may be
removed and recycled from sorted MHC-II upon action
of deubiquitinating enzymes [16]. Eventually, MHC-II
reaches intraluminal membranes, whose composition
greatly differs from that of the limiting membrane.
ILVs are highly enriched in cholesterol and tetraspanin
proteins (CD63, CD81 and others) [17], and sequestra-
tion of MHC-II in the lumen of the MIIC may, there-
fore, have functional consequences. Indeed, FRET
studies have indicated that MHC-II and HLA-DM
interact on ILV membranes, rather than on the limiting
membrane of the MIIC [18], implying that MHC-II
peptide loading may comprehensively occur on internal
vesicles. While intraluminal tetraspanin networks have
been suggested to stabilize DM-MHC-II interactions
and facilitate peptide loading on ILVs [19], cholesterol
likely plays a substantial role in MHC-II intracellular
traffic [20].
In immature APCs, MHC-II-positive ILVs are eventually
degraded in lysosomes or released from the cell as exo-
somes [21]. Following encounter with a pathogen, how-
ever, MIICs transition from ILV-rich antigen-producing
and loading factories to tubular organelles, poised for
transport of mature MHC-II complexes to the plasma
membrane for recognition by T cell receptors [22]. How
the MIIC is organized and remodeled to best serve the
host during different stages of the infection process—and
how these same attributes can be utilized by the pathogen
to gain advantage over the host—is discussed below.www.sciencedirect.com
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Table 1
Open issues on endosomal modulation in the context of antigen
presentation
Issue
Endosomal modulations in autoimmune diseases
The regulation of autophagy in TECs
Pathogen-mediated alterations of the endocytic network in APCs
The molecular mechanism of retrofusion
Functional differences between ILVs and the limiting membrane of the
MIIC
ER-mediated control of endosomal processes in professional APCs
The molecular pathway leading to endosomal tubulation and
transport upon maturationBefore the invasion—organization of the
endolysosomal system in immature APCs
In numerous APCs, including macrophages and immature
monocyte-derived DCs (moDC), the endolysosomal sys-
tem features a bilateral architecture, comprised of a rather
immobile perinuclear (PN) vesicle cluster, or ‘cloud’, and a
highly dynamic peripheral pool of endosomes and lyso-
somes [23]. The fate of individual vesicles in either region
of the cell relies on small GTPases, which determine
directionality of transport between the PN cloud and the
periphery and orchestrate maturation and cargo exchange
[24]. Through interactions with various effector proteins,
GTPases of the Rab, Arf, and Arl families couple vesicles to
microtubule motors for directional transport and mediate
recruitment of remodeling factors required for membrane
fusion and fission. At least two GTPases, Rab7 and Arl8b,
associated with late endosomes and lysosomes, oversee
traffic flow along the antigen processing and presentation
cascade(Figure 1) [25,26].Rab7, incomplexwith its effector
Rab-interacting lysosomal protein (RILP) and the microtu-
bule-based dynein motor, transports maturing endosomes
including those containing antigens toward the PN cloud,
where degradation occurs. Rab7 then collaborates with
Arl8b through a shared effector Pleckstrin homology
domain containing protein family member 1 (PLEKHM1)
and its associated homotypic fusion and protein sorting
(HOPS) complex to promote fusion between late endo-
somes and lysosomes [27], thereby ensuring cargo degra-
dation and acquisition of antigenic peptides by MHC-II.
Spatiotemporal regulation of endolysosomal organization
and behavior is not only autonomously determined, as
described above, but is also influenced by other orga-
nelles, most notably the endoplasmic reticulum (ER). For
instance, endosomes entering the PN cloud can be
anchored and retained through interactions with the peri-
nuclear ER-associated ubiquitin ligase Ring finger pro-
tein 26 (RNF26), and this ER docking facilitates access of
incoming vesicles to late compartments (Figure 1) [23].
Furthermore, fission of endosomes is also curated by the
ER [28,29]. As these processes are crucial for faithful
sorting and timely delivery of internalized materials for
proteolysis, it stands to reason that their underlying
mechanisms would also influence efficiency of antigen
processing and peptide loading, although formal investi-
gation thereof remains to be performed (Table 1).
The fight is on—architectural changes in the
endolysosomal system upon APC maturation
In the early steps of pathogenic invasion, APCs become
activated upon binding of innate immune receptors, such
as Toll-like receptors (TLRs), to pathogenic ligands and
integration of inflammatory mediators produced by other
cell types. As a result, APCs embark on a cell-wide
maturation program, which transiently increases MHC-
II biosynthesis, inhibits antigen acquisition through non-
specific phagocytosis and macropinocytosis [4], andwww.sciencedirect.com demands dramatic reorganization of the MIIC architec-
ture [4]. Following activation, MIICs transition from true
MVBs to tubular endolysosomes devoid of internal mem-
branes in order to allow efficient trafficking of peptide-
loaded MHC-II (p-MHC-II) to the plasma membrane for
presentation [30,31]. How MHC-II is transferred from
ILVs to the limiting membrane of the MIIC is unclear. It
has been speculated that, following APC activation, pre-
existing multi-vesicular MIICs would fuse with lyso-
somes, leading to degradation of pre-loaded MHC-II
residing on internal membranes. Meanwhile, newly syn-
thesized MHC-II would traffic to these late compart-
ments but avoid being sorted into ILVs due to suppressed
ubiquitination [32], remaining instead on the limiting
membrane for peptide loading and transport. However,
this supposition is challenged by the observation that
most p-MHC-II complexes are delivered to the plasma
membrane before MHC-II ubiquitination and sorting are
downregulated [30,33]. So how then does peptide-loaded
MHC-II arrive at the limiting MIIC membrane to enter
tubules for transport? It has been proposed that instead of
suffering degradation, ILVs harboring p-MHC-II fuse
back with the limiting membrane of the MIIC through
a process termed ‘retrofusion’ (Figure 2) [34–36]. The
existence of such a path for ILVs carrying p-MHC-II
complexes would explain a number of observations.
Firstly, the notion that surface p-MHC-II originates from
cholesterol-laden ILVs is notably consistent with the
finding that MHC-II arrives at the plasma membrane
in cholesterol-rich microclusters [37]. More importantly,
since APC stimulation occurs concurrently with the
acquisition and processing of pathogenic antigens, the
abundant luminal pool of p-MHC-II constituted before
maturation likely encompasses a myriad of pathogen-
specific epitopes, and its elimination would be counter-
productive to antigen presentation. Retrofusion would
thus offer a path for rescue of these epitopes from
lysosomal degradation, allowing them to be presented.
In the end, the two models for MHC-II transfer probably
coexist, and p-MHC-II complexes from all possible
sources contribute to antigen presentation in order to
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Schematic overview of MHC-II antigen presentation in maturing APCs.
Upon recognition of pathogens by receptors, such as TLRs, APCs undergo a process of maturation, during which global rearrangements of the
endolysosomal system take place. In the MIIC, retrofusion of ILVs and restriction of intraluminal sorting may allow p-MHC-II complexes to reach
the limiting membrane of the endolysosome. BORC-mediated recruitment of Arl8b to the MIIC leads to engagement of kinesin-1 motor that drives
elongation of MHC-II-positive membranes into tubules toward the microtubule plus-end. Concomitantly, Rab7-RILP-dynein transport complex
provides an opposing force necessary to induce membrane fission. Once the resulting MHC-II carriers reach the periphery, they fuse with the
plasma membrane to expose p-MHC-II complexes for T cell recognition.Given its small physical scale and dynamic nature, the
process of retrofusion has not yet been directly observed
(Table 1). However, viruses and toxins have been
described to hijack this pathway, following endosomal
entry, in order to reach the cytosol of the host cell and
achieve infection [38–40]. Similarly, it has been specu-
lated that retrofusion may allow access of exosome encap-
sulated material to the cytosol of target cells [41].
‘Ins’ and ‘outs’ of MHC-II transport to the cell
surface
Once p-MHC-II complexes have reached the limiting
membrane of the MIIC, they are sorted into tubules
destined for transport to the cell periphery. Subsequent
fusion of p-MHC-II positive tubules with the plasma
membrane implants these antigen epitopes for T cell
recognition. While retrograde transport to the perinuclear
region is governed by dynein, as described above, anter-
ograde transport toward the plasma membrane relies onCurrent Opinion in Immunology 2019, 58:1–8 kinesin-1 motor activity [42,43]. Intriguingly, both anter-
ograde and retrograde transport appear to be essential for
MHC-II delivery to the cell surface. In macrophages,
lysosomal tubulation requires both Rab7 and Arl8b, and
lipopolysaccharide (LPS) stimulation triggers this process
in a mammalian target of rapamycin (mTOR)-dependent
manner [44,45]. It is thought that Arl8b-mediated kine-
sin-1 activity drives lysosomal elongation into tubules,
and together with the counter force provided by the
Rab7-dynein complex results in tubule fission and liber-
ation of p-MHC-II carriers (Figure 2) [46]. Recent work
reveals that TLR-dependent engagement of the mTOR
axis induces membrane accumulation of Arl8b [45], but
the precise molecular underpinnings thereof remain
unexplored (Table 1). The multisubunit BLOC-one-
related complex (BORC) known to stimulate Arl8b
recruitment and influence positioning of lysosomes in
the cell periphery is likely involved [47–49], but the
existence of additional regulatory layers cannot bewww.sciencedirect.com
The endolysosomal system in antigen-presenting cells Perrin et al. 5excluded. Rab7 can also mediate endolysosomal transport
to the cell periphery via its effector FYVE and coiled-coil
(CC) domain-containing protein (FYCO1) [50]. Whether
this trafficking route participates in delivery of p-MHC-II
complexes to the plasma membrane of APCs is not
known.
Collectively, diverse transport systems are needed to
properly control traffic of MHC-II-containing vesicles
to the plasma membrane during APC maturation. Inter-
estingly, although the same machineries are also present
in immature APCs, in the absence of appropriate triggers,
MIICs do not migrate to the cell surface, suggesting the
existence of inhibitory mechanisms. Indeed, in a multi-
dimensional depletion screen the small GTPase Arl14/
Arf7 was identified as a negative regulator of MHC-II
export in moDCs [51]. Association of Arl14 with Arf7
effector protein (ARF7EP) causes recruitment of motor
myosin 1E for anchorage of MIICs to the actin cytoskele-
ton (Figure 1). By contrast, inactivation of this system in
immature DCs sends MHC-II molecules to the cell
surface, recapitulating a mature DC phenotype in the
absence of activation (Figure 2).
Once the export of peptide-loaded MHC-II complexes is
achieved, their stable residence at the plasma membrane
is protected to ensure longevity of antigen presentation
[52]. If endocytosed, owing to lack of ubiquitination, p-
MHC-IIs recycle back to the cell surface, instead of
following the degradation route [53]. Hence, MHC-II
ubiquitination must be tightly controlled to best serve

















MIIC matu ration --> self -Ag
AUTOIMMUNI TY(a) (b) IMMUNE  EVASION
Alterations in the MHC-II endocytic pathway can promote immune evasion 
(a) Salmonella bacteria evade host antigen presentation by manipulating the
regulates MARCH8-mediated ubiquitination of endocytosed p-MHC-II comp
in MHC-II and/or antigen trafficking pathway can result in aberrant antigen 
type lectin CLEC16A enhances maturation of MHC-II positive endosomes, l
MIIC biogenesis allows for loading and presentation of self-antigens and ma
delivers auto-antigens to the MIIC for loading and presentation by MHC-II. 
autophagy pathway in DCs through CTLA-4 engagement and subsequent a
www.sciencedirect.com example, in germinal centers, B cells are selected based
on their ability to capture and present antigens to T
helper cells. In order to favor their selection and prolifer-
ation, these cells modulate MARCH1-mediated ubiqui-
tination of MHC-II dimers to promote presentation of
their most recently acquired antigens [54]. Timely tun-
ing of MHC-II turnover, therefore, contributes to the rise
of high-quality antibody responses. In contrast, when
triggered by pathogens, aberrant ubiquitination and sur-
face depletion of mature MHC-II dimers can have dra-
matic consequences on T cell activation. For instance, the
gram-negative bacteria Salmonella enhances MARCH8-
dependant ubiquitination of endocytosed p-MHC-IIs,
thereby hampering their recycling and dampening anti-
gen presentation to T cells (Figure 3) [55]. Taken
together, these studies illustrate the power of modulating
ubiquitination status of MHC-II and suggest avenues for
intervention through transient inhibition of the enzy-
matic activities involved.
Antigen presentation and tolerance: how
alterations in MHC-II traffic and autophagy set
off autoimmunity
Because APCs play a pivotal role in the rise of immune
defenses, tight control over their function is essential for
immune tolerance. Deregulation of MIIC distribution can
lead to excessive antigen presentation and result in auto-
immune disorders. For instance, the C-type lectin
CLEC16A was identified as a factor responsible for such
deregulations in a genome-wide screen combined with
multiple sclerosis data sets [56]. Increased expression of
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and lead to autoimmunity.
 endocytic route of MHC-II. Salmonella’s effector SteD positively
lexes, preventing their recycling to the cell surface. (b,c) Malfunctions
presentation and lead to autoimmunity. (b) In multiple sclerosis, the C
ikely through interacting with RILP and the HOPS complex. Altered
y trigger an autoimmune response. (c) The autophagy pathway
In order to prevent autoimmunity, regulatory T cells disrupt the
ctivation of the PI3K/Akt/mTOR pathway.
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6 Antigen processingcould affect CD4 T cell activation and result in autoim-
mune response (Figure 3). Since it associates to RILP and
the HOPS complex, CLECL16A may affect transport
and fusion of MHC-II-carrying endosomes with lyso-
somes and thus alter MHC-II peptide loading and pre-
sentation of autoantigens. Hence, conservation of self-
tolerance not only requires proper MHC-II trafficking,
but also depends on the delivery of self-antigens to MHC-
II carriers. This can be achieved by macroautophagy,
when cytosolic substrates reach the endocytic network
in autophagosomal membranes. In DCs, fusion of autop-
hagosomes with MIICs leads to processing and loading of
cytosolic self-antigens onto MHC-II for presentation to
effector T cells. Interestingly, Foxp3+ Treg cells disrupt
autophagy in DCs (draining lymph nodes, splenic, and
bone marrow-derived DCs) through CTLA-4 engage-
ment and consecutive activation of the PI3K/Akt/mTOR
pathway (Figure 3) [57]. The resulting deficiency
reduces CD4 T cell auto-reactivity and lowers the risk
of autoimmunity.
In contrast, autophagy in thymic epithelial cells (TEC)
drives presentation of self-antigens to thymocytes and has
thus been implicated in T cell selection [58,59].
CLEC16A was recently found to influence thymic selec-
tion via autophagy, and its depletion could counter the
development of autoimmunity [60]. Precisely how
CLEC16A regulates TEC autophagy is unknown, but
it may involve modulation of mTOR activity [61], as well
as implicate RILP and HOPS. The latter option is sub-
stantiated by the finding that transport and fusion of
autophagosomes with late endosomes and lysosomes
are timed by several Rab7 effectors, including RILP,
PLEKHM1 and the cholesterol sensor ORP1L [62].
Specifically, these processes are sensitive to the presence
of cholesterol in endolysosomal membranes, as choles-
terol depletion forces Rab7-bound ORP1L to mediate
contacts with the ER. As a consequence, retrograde
transport and maturation of autophagosomes are inhib-
ited. It is, therefore, plausible that CLEC16A interven-
tion at this juncture may alter decisive steps in autophagy
to influence immune tolerance.
Conclusions and perspectives
The endosomal pathways of cells entrusted with respon-
sibilities of antigen processing and presentation are more
diverse and dynamic than originally anticipated. The
architecture and dynamics of the endolysosomal system
in APCs are controlled by various factors, which ulti-
mately determine healthy MHC-II responses. New
insights on this complex network of vesicular organelles
discussed in this review expand our perception of MHC-
II function, and its numerous forms of modulation, and
edify our understanding of the MHC-II compartment to
illustrate how endosomal regulators contribute to scrupu-
lous immune responses and tolerance. Deciphering how
the endolysosomal architecture is modified in the courseCurrent Opinion in Immunology 2019, 58:1–8 of infections and autoimmune diseases (Table 1) will help
define therapeutic targets and ultimately to design appro-
priate clinical strategies. The first examples are now at
hand.
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